相关实验视频
Updated: Jun 30, 2025

07:47
Measuring Delay Discounting in Humans Using an Adjusting Amount Task
Published on: January 9, 2016
15.4K
一种基于折扣因子的贝叶斯方法,用于在多区域临床试验中评估一致性
Liang Tong1,2, Chen Li1,3, Jielai Xia1,3
1Department of Health Statistics, Faculty of Preventive Medicine, Air Force Medical University, Xi'an, Shaanxi, China.
Journal of biopharmaceutical statistics
|March 20, 2024
概括
这项研究引入了一种新的贝叶斯方法,用于多区域临床试验 (MRCT),以评估区域疗效. 这种新方法考虑了折扣因子 (D) 的变化,改进了传统的频率统计方法,以获得更可靠的药物开发.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 药物开发 药物开发
背景情况:
- 多区域临床试验 (MRCT) 对全球药物开发至关重要,需要对区域疗效进行强有力的一致性评估.
- 像加权Z测试和折扣因子方法这样的现有方法在实际意义和可变性考虑方面存在局限性.
- 折扣因子方法虽然是一种改进,但将D因子视为固定的,可能导致不合理的结果.
研究的目的:
- 提出一种新的贝叶斯方法来评估MRCT中的治疗效果.
- 通过纳入折扣因子 (D) 的变化来解决频率统计方法的局限性.
- 提高全球药物开发中的一致性评估的准确性和可靠性.
主要方法:
- 开发了一种贝叶斯方法,将折扣因子 (D) 视为具有指定β分布的随机变量.
- 根据模拟结果调整了贝叶斯式方法,以进一步完善其性能.
- 使用马尔科夫链蒙特卡洛 (MCMC) 模拟来说明拟议方法的应用.
主要成果:
- 建议的贝叶斯方法成功地结合了折扣因子 (D) 的变化.
- 模拟结果表明,将D视为随机变量会导致更合理的疗效评估.
- 与固定因素方法相比,该方法提供了对目标区域治疗效果的更细致的评估.
结论:
- 新的贝叶斯方法为MRCT的一致性评估提供了显著的进步.
- 考虑到折扣因子 (D) 的变化,可以更好地评估区域有效性.
- 该方法通过增强的临床试验分析,支持更可靠和实用的全球药物开发.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Pharmacokinetic Models: Comparison and Selection Criterion
71
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
71
Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
Study Design in Statistics
8.0K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.0K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69

